Leading antibody discovery and development company.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2020 | FORBES-TATE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2020 | FORBES-TATE |
4th Quarter (Oct 1 - Dec 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| FORBES-TATE | 15 | — |
| Issue | Activities |
|---|---|
| Health Issues | 14 |